Gold Member Since 2014
Audited Supplier
Hubei Yuancheng Saichuang Technology Co., Ltd.

Cabergoline, Pharmaceutical Raw Material, Pharmaceutical manufacturer / supplier in China, offering High Purity Pharmaceutical Raw Material Cabergoline, High Purity Pharmaceutical Raw Material Rapamycin, 1295 Peptides Raw Drugs Cjc1295 and so on.

(/ )

Supplier Homepage Product Pharmaceutical Intermediate High Purity Pharmaceutical Raw Material Cabergoline

High Purity Pharmaceutical Raw Material Cabergoline

FOB Price: US $50 / mg
Min. Order: 100 mg
Min. Order FOB Price
100 mg US $50/ mg
Get Latest Price
Production Capacity: 2kg/Month
Transport Package: 1g/Foil Bag
Payment Terms: T/T, Western Union, Money Gram, bitcoin

Request a custom order and have something just for you!

Send Customized Request
Basic Info
  • Model NO.: 81409-90-7
  • Customized: Customized
  • Suitable for: Adult
  • Purity: >98%
  • CAS: 81409-90-7
  • MW: 451.6
  • Appearance: White Powder
  • Specification: enterprise standard
  • HS Code: 2939630090
  • Powder: Yes
  • Certification: ISO 9001
  • State: Solid
  • Name: Cabergoline
  • Mf: C26h37n5o2
  • Assay: 98%
  • Trademark: Saichuang
  • Origin: Wuhan
Product Description
Cabergoline
CAS: 81409-90-7
MF: C26H37N5O2
MW: 451.6
Purity:98%
Appearance:white powder
Cabergoline an ergot derivative, is a potent dopamine receptor agonist on D2 receptors. Rat studies show cabergoline has a direct inhibitory effect on pituitary lactotroph (prolactin) cells.It is frequently used as a first-line agent in the management ofprolactinomas due to higher affinity for D2 receptor sites, less severe side effects, and more convenient dosing schedule than the older bromocriptine.
Uses:
hyperprolactinemia
adjunctive therapy of prolactin-producing pituitary gland tumors (prolactinomas);
monotherapy of Parkinson's disease in the early phase;
combination therapy, together with levodopa and a decarboxylase inhibitor such as carbidopa, in progressive-phase Parkinson's disease;
in some countries also: ablactation and dysfunctions associated with hyperprolactinemia (amenorrhea, oligomenorrhea, anovulation, nonpuerperal mastitis and galactorrhea);
treatment of uterine fibroids.
adjunctive therapy of acromegaly, cabergoline has low efficacy in suppressing growth hormone levels and is highly efficient in suppressing hyperprolactinemia that is present in 20-30% of acromegaly cases; growth hormone and prolactin are similar structurally and have similar effects in many target tissues, therefore targeting prolactin may help symptoms when growth hormone secretion can not be sufficiently controlled by other methods


Follistatin 3441mg/vial
Follistatin 3151mg/vial
Epitalon10mg/vial
ACE 0311mg/vial
Adipotide2mg/vial
AOD-96042mg/vial
GDF-81mg/vial
Deslorelin20mg/vial



NameQuantity/vial
MGF2mg
PEG MGF2mg
CJC-1295 with DAC2mg
CJC-1295 without DAC2mg
PT-14110mg
MT-110mg
MT-210mg
GHRP-25mg
GHRP-210mg
GHRP-65mg
GHRP-610mg
Ipamorelin2mg
Hexarelin2mg
Sermorelin2mg
Oxytocin2mg
TB5002mg
Pentadecapeptide BPC 1572mg
 2mg
Triptorelin2mg
Tesamorelin2mg
Gonadorelin2mg
Gonadorelin10mg
DSIP2mg
Selank5mg
Send your message to this supplier
Avatar
Miss Sherry
*From:
To: Miss Sherry
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

Find Similar Products By Category